Alzheon Prices IPO at $13.00-$15.00 Per Share (ALZH)

Share on StockTwits

Alzheon (ALZH) expects to raise $35 million in an IPO on Wednesday, October 24th, IPO Scoop reports. The company will be issuing 2,500,000 shares at $13.00-$15.00 per share.

The company has a market cap of $191.6 million.

ThinkEquity (A division of Fordham Financial Management) and H.C. Wainwright & Co. acted as the underwriters for the IPO and H.C. Wainwright & Co. was co-manager.

Alzheon provided the following description of their company for its IPO: ”  We are a clinical stage biopharmaceutical company with a late-stage program in Alzheimer’s disease and a discovery platform of small molecules for the inhibition of protein misfolding and aggregation in neurodegenerative disorders. Protein misfolding is an abnormal process in which a protein fails to fold in its normal configuration, rendering the protein toxic or inactive. Our goal is to develop disease modifying treatments for patients with Alzheimer’s and other neurological disorders by leveraging our expertise in inhibiting protein misfolding and aggregation. “.

Alzheon was founded in 2013 and has 6 employees. The company is located at 111 Speen Street, Suite 306, Framingham, MA 01701, US and can be reached via phone at (508) 861-7709 or on the web at http://www.alzheon.com.

Receive News & Ratings for Alzheon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alzheon and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Laurion Capital Management LP Takes $738,000 Position in Sally Beauty Holdings, Inc.
Laurion Capital Management LP Takes $738,000 Position in Sally Beauty Holdings, Inc.
30,000 Shares in A10 Networks Inc  Acquired by King Luther Capital Management Corp
30,000 Shares in A10 Networks Inc Acquired by King Luther Capital Management Corp
OppenheimerFunds Inc. Decreases Position in 3M Co
OppenheimerFunds Inc. Decreases Position in 3M Co
Pacific Biosciences of California  Position Trimmed by Mutual of America Capital Management LLC
Pacific Biosciences of California Position Trimmed by Mutual of America Capital Management LLC
Sierra Metals  Upgraded to Hold at Zacks Investment Research
Sierra Metals Upgraded to Hold at Zacks Investment Research
JPMorgan Chase & Co.  Earning Somewhat Favorable Press Coverage, Analysis Shows
JPMorgan Chase & Co. Earning Somewhat Favorable Press Coverage, Analysis Shows


© 2006-2018 Ticker Report